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Abstract. Since the gene splicing debates of the 1980s, the public
has been exposed to an ongoing sequence of genetic and reproduc-
tive technologies.  Many issue areas have outcomes that lose track of
people’s inner values or engender opposing religious viewpoints defy-
ing final resolution.  This essay relocates the discussion of what is an
acceptable application from the individual to the societal level, ex-
amining technologies that stand to address large numbers of people
and thus call for policy resolution, rather than individual fiat, in their
application.  A major source of guidance is the “Genetic Frontiers”
series of professional dialogues and conferences held by the National
Conference for Community and Justice from 2002 to 2004.  Ge-
netic testing, human gene therapy, genetic engineering of plants and
animals, and stem cell technology are examined.  While differences
in perspective on the beginning of life persist, a stepwise approach to
the examination of genetic testing reveals areas of general agreement.
Stewardship of life, human co-creativity with the divine, and social
justice help define the bounds of application of genetic engineering
and therapy; compassionate care plays a major role in establishing
stem cell policy.  Active, sustained dialogue is a useful resource for
enabling sharing of religious values and crystallization of policies.
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Profoundly life-shaping genetic technologies have arisen over the last three
decades, with an acceleration in technologic development since the advent
of the Human Genome Project and the first human gene therapy trials of
the early 1990s.  Discussion of the role bioethicists have played in enumer-
ating the broader merits and drawbacks of these developments crops up
with surprising frequency whenever interdisciplinary scholars gather to re-
flect on the human genome.  It is clear that sometime in the late 1960s a
division formed between secular and moral/religious ethicists and equally
clear that a premium is now being placed on religious perspectives on ge-
netic developments.  Faith-based approaches often embrace traditional ethi-
cal principles such as beneficence and social justice, but they go one step
further in using principles that apply to the natural course of human exist-
ence, with all its needs, emotions, and limitations, as well as the recorded
log of principles emanating from God’s interaction with humanity.  Reli-
gious principles do not conform to the same types of validity tests as do
empirical scientific studies and logical syllogisms but gain legitimacy through
repeated application to life experience accumulated over many generations.
This storehouse of wisdom is available to shed light on genetic research
and its applications.  New forms of genetic testing and reproductive tech-
nology arise in the blink of an eye, by historical standards, and stand to
benefit from religious insight.
Debates about the use of stem cells and the application of techniques
such as prenatal testing and cloning often reach loggerheads between the
disagreeing parties.  Interest groups—corporations, scientific organizations,
and advocacy groups—enter the fray and attempt to resolve the issues
through political persuasion.  Worse yet, the technology is offered up to
the open market, which decides its fate for mainstream use.  When the
market is resorted to, as it has been for the clinical delivery of reproductive
services, often only individuals able to afford the expensive technologies
have access.  The demand from a limited clientele determines their use.
Citizens who cannot afford the service, or who have alternative sugges-
tions based on their faith-based preferences, get sidelined.  This removal
explains why input from multiple parties is needed.  The perspectives to be
shared are not just ethical in the strict academic sense but also are moral
(based on customs and traditions) and religious.
In this essay I present religious perspectives on a range of genetic and
reproductive (reprogenetic) technologies, from prenatal testing to the use
of stem cells.  The approach is eclectic, drawing examples and commen-
tary from a variety of groups and literary sources.  Chief among the sources
are strands of thought developed over a three-year period (2002–2004) by
participants taking part in “Genetic Frontiers: Challenges for Humanity
and Our Religious Traditions,” a program hosted in Detroit, Michigan, by
the National Conference for Community and Justice (NCCJ).  Following
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examination from a religious perspective of four major categories of tech-
nology, I consider the merits of dialogue for resolving controversies of adop-
tion and application, then seek common ground.
The funded program consisted of a nine-part professional dialogue se-
ries and three major conferences combining professional and lay members.
The technologies reviewed here correspond to the array of topics that par-
ticipants in the program discussed.  Because genetic and reproductive tech-
nologies that can be afforded by the few often receive input only from the
few and can be purchased despite vast areas of consumer disagreement,
this essay emphasizes technologies that have a clear population relevance.
Technologies that apply to the many are most likely to strike areas of agree-
ment in their application.  Prenatal genetic testing has now been used for
more than three decades, and it launches our inquiry.
PRENATAL GENETIC TESTING
The first set of ethical challenges for genetic medicine arises from genetic
testing, which is aimed at the health of individuals.  Many types of genetic
testing are in use, including preconceptual testing, prenatal testing, adult
carrier testing, and predispositional testing.  Prenatal testing generally has
produced the largest basket of moral challenges, because it can lead to a
decision to abort the fetus after nine weeks of gestation.  This is by no
means the only possible decision for couples using prenatal testing ser-
vices, however.  Such testing can introduce certainty into a situation where
couples are concerned about the fate of their at-risk fetus and would other-
wise be inclined to abort if the results of prenatal testing were not available
to them.  Some religious bodies permit prenatal testing so long as the ex-
pected benefit to the fetus is greater than the foreseen risks (Roman Catholic
Church), and if it is of benefit to both mother and child (Episcopal Church)
(Anderson 2002, RCC-1, EC-1).
Starting in the early 1970s, Jewish bioethical literature began to con-
template—or, more appropriately, to argue—the pros and cons of abor-
tion for Tay-Sachs disease from a theological point of view (Jacobs 1977,
79; Rosner 1976, 275).  Talmudic scholars view the beginning of human
life as taking place after forty days (at which point the fetus is no longer
considered liquid), with full moral rights not acquired until the infant is
actually born (Rosner 1991a, 136).  The forty-day limit suggests why Or-
thodox Judaism has been against fetal termination, instead opting for al-
ternative approaches such as preconceptual testing (Tendler 1990, 118).
(The corresponding figure by Islamic authorities is one hundred twenty
days (Al-Aqeel 2005, 1867).)  Tay-Sachs disease is a pernicious condition
leading to blindness, paralysis, and inexorable death by four years of age.
It is exemplary among genetic diseases as a condition that demands atten-
tion, regardless of where one falls along the orthodoxy-liberalism spectrum.
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Less hazardous genetic conditions pose more vexing moral challenges,
because a lessened disease severity can allow a higher if not fully enjoyed
quality of life, and the possibility of death is remote.  Two conditions con-
sidered on several occasions throughout the NCCJ series, Down syndrome
and congenital deafness, call for interventions with arguable levels of ne-
cessity.  Amniocentesis—removal of amniotic fluid for prenatal testing—
offers the possibility of testing for neural tube defects and Down syndrome.
Bioethicists early on considered the ethical pluses and minuses of letting a
child with a neural tube defect and a blocked or atretic intestinal tract
perish on its own, rather than performing restorative surgery.  The deci-
sion often followed a straightforward utilitarian calculus.
Down syndrome (extra chromosome 21) need not present with the haz-
ards of neural tube defects, though.  Indeed, Down syndrome is often a
mosaic condition in which the individual inherits a fair share of unaffected
cells in addition to those cells displaying the trisomy.  Consequently, the
child may end up quite suited for life and able to enjoy a high quality of
existence, despite some level of mental impairment.  The decisional focus,
therefore, shifts from the moral rights of a fatally or severely affected future
person to that of the sanctity of human life occupying a range of living
functionality.  The couple may choose to focus on the stresses they will
bear by bringing a Down child into existence, but an ethos of compassion,
so emphasized in all religions, East and West, may also serve as a guiding
principle.  They may choose not to abort but to prepare for the emergence
of a child with Down syndrome.  As one professional participant put it,
“We are all born with the image of God in us. . . . God can turn weakness
to strength.  A Down syndrome child can bring much love into the family.”
Congenital deafness offers the opposite situation.  Deaf couples for the
most part treasure their special identity and would hope to have a deaf
child to live with them in the signing community.  Many congenitally deaf
couples resist the opportunity to have cochlear implants inserted into their
progeny, because the ability to hear would effectively cut them off from
the deaf community.  Abortion of a future deaf child would not even enter
their minds.  Ironically, instances of deaf couples asking their physician to
either grant them a deaf child or abort the fetus have been reported, though
this type of request is not the norm.  Bioethics literature points out that
refusal to consider a cochlear implant and actively seeking to have a deaf
child through prenatal means may foreclose the child’s right to an oppor-
tunity-rich “open future” (Davis 1997, 12–14).  Deliberately creating a
child to fit the parents’ image of “the good life” would seem to contradict
the Kantian principle of treating each person as an end in him- or herself
rather than a means to an end.
More transcendent principles would seem to apply when either deaf or
non-deaf parents are considering abortion to achieve a certain preferential
end.  Conference and dialogue series participants often evoked the imago
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dei (image of God) concept: Humans are created in the image of God, and
God shows divine care for humankind.  This principle points toward the
irrevocable value of human life with natural limits or constraints set jointly
by God and nature, each in their own wisdom.  The innate value of human
life further suggests the equality of human life, whether or not the life
displays what may be considered a genetic condition.  A deaf child for a
deaf (or non-deaf ) couple shares the same right to life as a non-deaf child
for a non-deaf couple.  Religious principles of compassion and the sanctity
of human life can easily insinuate into any birth decision in which quality
of life is at issue.
PREIMPLANTATION GENETIC DIAGNOSIS AND PRECONCEPTUAL
GENETIC TESTING
The desire to avoid aborting a fetus with a genetic condition can lessen as
the condition becomes more severe and incapacitating but also if the deci-
sion to abort comes earlier in gestation.  Translated into the public sphere,
this is the reason why the United States Congress passed the Partial Birth
Abortion Act prohibiting abortion of the fetus with any part of its body
surgically pulled outside the womb (a procedure that might be performed
during the third trimester) while allowing the general act of abortion (usu-
ally relegated to the first two trimesters) to remain the decision of the
mother (Roe v. Wade).  Legality, of course, is different from morality, and
many couples with religious convictions oppose the idea of abortion in
any trimester.
Orthodox Jewish couples where both spouses carry a Tay-Sachs muta-
tion may resort to an option that avoids fetal termination: preimplanta-
tion genetic diagnosis (PGD).  This procedure involves screening the egg
at the very early four- to eight-cell stage after fertilization in vitro.  Faith
traditions differ on the acceptability of in vitro techniques, which bypass
the natural conjugal act between spouses but satisfy the biblical injunction
to be fruitful and multiply.  Many Jewish and Islamic theologians would
say that the embryo at this early stage has elements of humanness but has
not yet attained human identity.  For many couples of these two faiths,
PGD is a way to avoid giving birth to a child affected with a genetic con-
dition that is not viewed as abortion (Al-Aqeel 2005, 1866; Broyde 2004,
65).  On average, 45 percent of couples in the Arab world today practice
marriage between blood relatives, so conditions such as spinal muscular
atrophy and thalassemia, a disease family related to sickle cell disease, is of
concern (Kershaw 2003, A3).
In Saudi society, the incidence of type-I diabetes is also on the rise.
Investigators have proposed using PGD not only for severe single-gene
conditions but also for chronic conditions such as hypercholesterolemia
and diabetes, which involve multiple gene and gene-environment interac-
tions yet still possess major gene loci.  Others have described how PGD
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could be used to eliminate late-onset single-gene conditions such as Hun-
tington disease, a wasting condition like Parkinson’s, in several genera-
tions.  One notes a drift in the suggested applications away from couples
facing having a child with a severe, possibly fatal, condition toward less
dire circumstances.  The contemplated applications either appear later in
life or touch on future generations.
Throughout the three Genetic Frontiers conferences hosted by NCCJ,
the speakers affirmed the duty to heal in the context of their own faiths.
The family is part of the healing unit and inevitably is affected in numer-
ous ways by the birth of a child with a severe genetic condition.  PGD is
certainly an option for families who may undergo appreciable future hard-
ship as a result of such a birth and who can afford the technique.  Fatima
Agha Al-Hayani, an Islamic scholar, noted that the public interest is also at
stake.  Addressing chronic conditions that could affect a large proportion
of the population may advance moral approval for this technique.  Jewish
bioethicists, however, have emphasized the value of restraint when consid-
ering innovative medical procedures and applications, so that more tradi-
tional and life-preserving approaches reserved for the future individual’s
adulthood might be viewed as taking precedence (Rosner 1991a, 190).
Rabbi Peter Knobel cited a duty to the generations, quoting Azriel
Rosenfeld on the management of serious genetic defects: “Our sages rec-
ognize and perhaps even encourage the use of prenatal (or better precon-
ceptual) influences to improve one’s offspring” (Knobel 2004, 10).  The
question is how far the duty to the generations extends.  A number of
bioethicists and rabbinic authorities have argued that the focus in gene-
selection techniques should be on the child and couple at hand and warn
that consideration of effects on the gene pool could run in eugenic direc-
tions.  Many participants in the Genetic Frontiers project voiced eugenic
concerns, paralleling similar concerns present in the bulk of denomina-
tional genetics policy statements (UMC 1992, 6; WCC 1989, 11; NCCC
1986, 4).  Knobel’s comments were lodged in reference to genetic engi-
neering of animals and humans.  This line of thought was part of a larger
discussion dealing with humanity’s biblically appointed dominion over and
stewardship of nature.  Religion, therefore, can be viewed as delineating
the lower and upper bounds of genetic technology applied to future gen-
erations.  Attempts to alter the human gene pool, and perhaps even to
move preimplantation techniques in the direction of trait selection, can be
viewed as outside the boundary of the acceptable.  Using genetic technol-
ogy to feed current and future generations merits different considerations.
It also should be noted that Roman Catholicism views the embryo as
having human identity and rights from the point of conception onward.
“From the time that the ovum is fertilized, a new life is begun . . . the life
of a new human being with its own growth” (Congregation for the Doc-
trine of the Faith 1987, 701).  In vitro techniques other than intracyto-
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plasmic sperm injection directly into the egg can involve considerable wast-
ing of seed, transgressing religious prohibitions across several faiths.  The
concern also exists that in vitro techniques like PGD devalue the loving
relationship at the heart of procreation and could lead to gradual societal
acceptance of designing babies (International Catholic University 2004,
13).  Roman Catholic policy statements do not sanction in vitro tech-
niques, of which PGD is one.  From this religious viewpoint, also shared
by Jewish Orthodoxy, avoiding having children with severe genetic condi-
tions must be accomplished through some other means.  That means is
preconceptual carrier testing to check whether both members of an at-risk
couple carry a single gene copy for the same genetic condition.  If they do,
adoption is one option.  However, in some cultures, this form of testing is
also used premaritally to promote the exchange of genetic information
between future spouses.
One factor that must be considered in the use of preconceptual testing
in a religious or cultural context is whether it will have a bearing on the
institution of marriage itself.  Persons known to be carriers of Duchenne
Muscular Dystrophy mutations have encountered increased difficulty in
finding marriage partners (Atkin and Ahmad 1998, 455).  Reports also
exist of disrupted marital engagements in hemoglobinopathy screening pro-
grams in the Mediterranean (for example, Orchomenos, Greece) (Atkin
and Ahmad 1998, 455; Wilfond and Fost 1990, 2781).  Stigmatization
can be an outcome of premarital genetic testing when the results are not
handled with sensitivity.
In multiple health contexts (spread of communicable disease, distribu-
tion of novel therapies, family-planning services in health-care plans), per-
sons of faith are challenged to simultaneously consider individual interests
and those of the family, community, or society.  In public health contact
tracing—HIV, for instance—privacy may be breached to protect others
from being infected.  The Dor Yeshorim programs in Jerusalem and Brook-
lyn have been used to inform Ashkenazic Jewish couples of marriages that
could lead to children with Tay-Sachs disease, Canavan neural degenera-
tive disease, and other potential genetic conditions.  The two factors can
be skillfully blended with concern for the religious community.  In Dor
Yeshorim, partners are notified when risk exists, but neither individual
learns exactly who carries a risk-conferring gene or whether they them-
selves have a single-gene copy for a genetic condition.  Coded results and
private communication of the information keep privacy at a maximum
(Rosner 1991b, 252).  The programs avoid stigmatization, at the same
time allowing couples to make crucial decisions to prevent, through pre-
conceptual means, having an affected child.  Community screening pro-
grams can honor religious precepts regarding the sanctity of human life
while granting couples a means of avoiding having children afflicted with
a severe genetic condition.
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HUMAN GENE THERAPY
In his inaugural keynote address for the Genetic Frontiers conferences,
Philip Hefner touched on a technology that has pertinence for current and
future generations: gene therapy.  Hefner cited both somatic cell gene
therapy and germ-line gene therapy.  Somatic cell gene therapy, aimed at
restoring bodily cells, has generally received approval by policymaking bodies
in the various denominations because it so directly carries forward the ethos
of healing (Nelson 1994, 180–82).  Cautionary secular bioethics literature
is rife with discussions on the issue of safety, especially concerning such
sophisticated genetic technologies as gene therapy.  Religious authorities
have also shown appropriate concern for safety issues, particularly for ex-
perimental procedures and those that might affect the environment (Nel-
son 1994, 180–82; Phan, Doukas, and Fetters 1995, 242–43).  Some
human gene therapy trials attacking cancer immunologically and treating
cardiovascular disease have shown efficacy with very little downside
(Lyngstadaas 2002, 654, 663).  Other trials in the news—the Jesse Gelsinger
case resulting in the 18-year-old’s death and the recent leukemia cases as-
sociated with X-linked severe combined immune deficiency (France)—
merit the secular and religious authorities’ cautions (Krimsky 2005, 10–11).
For the phenomenon of aging, to which no one is immune, religion
would seem to suggest a wider approach.  Scientists have tinkered with the
possibility of chromosomal repair through telomerase gene therapy, but
pharmaceutically induced caloric restriction that might alter the body’s
energy substrates through down-regulation of intranuclear signaling sys-
tems seems a more likely prospect for retarding aging (President’s Council
on Bioethics 2003, 4–6).  Conference participants saw pluses and minuses
to this ambition: It could allow time for mastery of one’s job or, indeed, for
several careers but could also societally deplete resources at the end of life.
Theologians such as Abraham Joshua Heschel and others of faith have
suggested not so much a staving off of the aging process as a renewal of the
inner, creative fabric of the family and community and an opportunity for
the individual to grow in the direction of greater personal meaning and
involvement in what is most meaningful (Heschel [1959] 1972, 78, 82).
These caveats do not obviate the value of attempts at life extension but
shift the focus in an existentially deeper direction.
On the other end of life, germ-line gene therapy (GLGT) targeting adult
reproductive cells, gametes, and/or early embryos poses overwhelming risks.
Errors unintentionally introduced into the genome would be perpetuated
into future generations.  As Hefner stated, we must consider how “our
interventions will affect future generations as yet unborn” (Hefner 2002a,
2).  This consideration especially will nullify any attempt to introduce
GLGT into the procession of human gene therapy trials in the foreseeable
future.
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Beyond safety issues, religious perspectives on genetic technologies stress
social justice.  Religious concern goes beyond the attention of secular eth-
ics to fairness in one-to-one relationships.  The focus is also on societal
patterns in the distribution of benefits and burdens, particularly for the
less well off (Chapman 2001, 134–35).  This priority arises from the Judaeo-
Christian precept that we are our brother’s keeper.  The argument often
has been made that the federal government should not be pumping so
much money into National Institutes of Health–sponsored human gene
therapy trials when so many other disease approaches, including other ge-
nomic strategies, deserve support.  This is quintessentially a scarce-resources
argument.  The industrial perspective is that more than 60 percent of gene
therapy trials are sponsored by corporate sources.  Nonetheless, corporate-
sponsored gene therapy trials, like their publicly sponsored counterparts,
can address the interests of only a few individuals at a time.  Only four
gene therapy products are currently undergoing Phase 3 investigation,
checking for efficacy at the human level.  It will be a long time before any
situation remotely approaching social justice will be achieved in the gene
therapy field.  The social-justice perspective does not suggest halting gene
therapy research but does temper the amount of social investment that
should be placed in this type of approach.
Arguments concerning funding and distribution inequities leave un-
touched larger ontological arguments connected with human drives.  The
space program and linear accelerators are also inordinately expensive, yet
this fact has not stopped progress in these areas.  What is afoot?  A main
contention of Hefner’s is that the development of genetic engineering and
similar biotechnologic advancements is an integral part of human nature.
“It would be very strange if issues [concerning their appropriateness] did
not appear on the scene at this point in human history” (Hefner 2002a, 2).
He asserts that the moral challenges posed by genetic engineering do not
arise because people these days are “sinful or perverted in some way, but
rather grow out of the givenness of our human situation today” (2002a, 2).
It is likely that scientists will continue progress in gene therapy, which is
one type of the broader category of genetic engineering.
GENETIC ENGINEERING OF PLANTS AND ANIMALS
Examples of plant and animal genetic engineering abound.  In the animal
category, genes have been inserted into pigs to increase musculature and
leanness and make them immune compatible to humans for implantation
purposes.  Sheep have been engineered to secrete pharmaceuticals in their
milk.  Salmon have been transformed into giant versions of their native
species.  In the plant category, characteristics such as hardiness, resistance
to drought, and protection from insect infestation have been genetically
introduced.  A gene for vitamin A production has been inserted into the
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rice genome (which scientists have now fully mapped), yielding a new spe-
cies called golden rice.  Then there are the epidemiologic facts: 1.3 billion
individuals throughout the world live in extreme poverty.  Two-thirds of
the world’s population live in constant hunger and malnourishment.  Given
this level of need, the ambition to improve food, nutrient content, and
pharmaceutical availability is laudable.
Genetic Frontiers participants identified two types of moral challenges
in connection with genetic engineering—metaphysical and ethical.  All
genetic engineering induces some change of identity.  When dealing with
plants and animals, the genes introduced may be from another species,
even from humans.  Therefore, natural species barriers are being broken.
This action requires hubris, as the full consequences of such actions can-
not be foreseen.  As professional dialogue series member Dr. Ernest Krug
phrased it, “Only God can know the consequences.”  The bovine serum
growth hormone being supplied to cattle, for example, has led to breast
and prostate cancer in recipient livestock.  Genetically modified corn is
toxic to the monarch butterfly.  A chaos theory saying is that the flap of a
butterfly’s wing in one location can cause a cyclone in another.   The same
could be said of the unanticipated consequences of genetic manipulations.
Deeper questions related to ownership also arise.  Though domesticated
animals, livestock, and hybrid plants are bred for human purposes, people
tend to view them as being originally created by the divine and thus in a
strong sense still owned by God.  When genes from widely different spe-
cies are commingled, who can say whether the taxonomy created is owned
by God?  Has a wide enough split been accomplished such that the species
created no longer partakes in God’s dominion and thus runs afoul of God’s
protection (or, scientifically speaking, the ecological processes that bring
species relationships into restorative balance)?  In the Bible (Masoretic text)
we read, “And God said: Let us make man in our image, after our likeness;
and let them have dominion over the fish of the sea, and over the fowl of
the air . . . and over all the earth” (Genesis 1:26).  In the next chapter,
however, “And the Lord God took the man, and put him into the garden
of Eden to dress it and to keep it” (2:15).  These two versions of humankind’s
creation in God’s image lead to different interpretations of the human re-
lationship with nature.  In the first, humanity was created to dominate
nature.  In the second, humanity is given stewardship over or responsibil-
ity for nature.  This is the image of the suffering servant, Jesus Christ,
endowed by God to embody divine purposes and presence in the world.
The two interpretations place the human being as “created co-creator” in a
position of inherent tension (Knobel 2004, 3).  According to Hefner, the
real challenge lies not so much in how we decide to best handle nature but
in how we adjust to a tension that is part of the essential makeup of every
human being.  In fact, Hefner believes we are at the dawn of a human
species transformation in which the biologic and electronic changes we are
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introducing are becoming an integral part of the human constitution.  We
are becoming “technosapiens” (Hefner 2003, 73; 2002b, 663).  If he is
correct, genetic engineering is a predictable accoutrement of human evo-
lution.
 The adjustment to living with our co-creatorship with God entails so-
cial responsibilities that ideally would be addressed concurrently with the
introduction of new biotechnologic procedures.  Workshop speakers in
the second Genetic Frontiers conference, “Genetics: Feast and Famine,”
voiced concern that the distribution of genetically modified foods to third-
world countries is not being done in a socially responsible manner.  Termi-
nator seed ostensibly was created to avoid the possibility of cross-pollination
with native plant species.  However, a seed that does not reproduce also
places users in a position of dependency to purchase more seed, most likely
from the same source, for the next planting.  And with regard to golden
rice, estimates are that one would need to consume fifteen pounds per day
to prevent blindness.  Critics argue that use of these bioengineered prod-
ucts could further impoverish farmers in the third world.
According to a Jewish principle, society is judged by how it treats its
weakest members.  In Roman Catholicism and other faiths, the dignity of
human life exists at every life stage and is to be respected, cherished, and
promoted in the weak and poor.  Respect for human dignity would play
out into policies touching on co-ownership in the fruits of bioengineering
and trust-building actions based on the concerns of recipient populations.
The religious conclusion regarding genetically engineered plants and ani-
mals is that such manipulations may be morally justifiable but that a siz-
able degree of scientific caution and social conscience needs to be employed
in harnessing this technology.  If a religiously informed global perspective
is adopted, large numbers of people stand to benefit.
STEM CELL TECHNOLOGY
Stem cells are pluripotent cells capable of self-renewal and differentiation
into a vast array of cell types.  Genetic engineering and stem cell technol-
ogy represent geometrically inverse approaches to the conquering of dis-
ease.  Genetic engineering changes the genetic material residing in the
nucleus of cells.  Stem cells are used to replace defective or degenerated
cells with fresh cells from the outside.  Human embryonic stem cell re-
search poses safety issues analogous to those of human gene therapy re-
search.  Deeper theological issues also plague the use of human embryonic
stem cells.  These cells may be derived from the germinal cells of aborted
fetuses or from discarded fertilized eggs donated by couples undergoing in
vitro fertilization.  Derivation of stem cells using the second technique
entails destruction of the developing embryo.  Death of the fetus or of the
embryo is the outcome in either case.  Religious groups such as the Na-
tional Conference of Catholic Bishops have declared that the generation
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and use of human embryonic stem cells is morally wrong because the iso-
lation of the stem cells inevitably involves the death of a developing hu-
man being (USCCB 2004, 6).  From this perspective, downstream use of
stem cells wraps the user in a state of complicit guilt, because the only way
the stem cells could be used is at the earlier expense of an embryo or fetus
(Doerflinger 1999, 141).
The use of somatic cell nuclear transfer, or cloning, to generate stem
cells fares no better, because many clones would be required to yield a few
viable stem cells.  Further, stem cell lines can be perpetuated over a multi-
tude of generations, but clones must be newly created, making them an
option acceptable to and affordable by few (USCCB 2004, 8).  Arguments
and counterarguments have been posed regarding the suitability of an-
other alternative, adult stem cells, for use in tissue replacement.  These
arguments not being resolved, a strong need still exists for consensus build-
ing over the use of embryonic stem cells.
The duty to heal has been alluded to as a primary moral obligation
throughout the major Western religions.  A Lutheran congregant may view
the healing imperative as being most important at the level of the indi-
vidual patient or sufferer.  A Jewish congregant may stipulate that the im-
perative should be applied to the health of members of the community.
Stem cells fit the bill from either perspective.  They can be applied to
individuals, and even derived from the individual who will ultimately ben-
efit.  Their development and use is not as expensive as that of somatic cell
gene therapy.  Therefore, stem cell technology stands a greater chance of
being used on a society-wide basis than does gene therapy.  For many, the
moral justification for human embryonic stem cell use rests on the im-
mense individual and societal benefit it potentially offers.  More than utili-
tarian reasoning underlies the proponents’ arguments, however, because
many of the diseases that could be treated involve considerable suffering or
have dehumanizing aspects.  The element of compassion by itself could be
(and in a sense already has been in the existent state and federal policies)
part of the driving force that overcomes the impasse left by the beginning
of life point-counterpoint.
Consternation over the use of cloning displayed by NCCJ conference
speakers was less evident when they referred to human embryonic stem
cell use.  A comment during the second conference on “Manipulating Life”
by Al-Hayani, that stem cells can “enhance health and replace limbs,” rep-
resented the material perspective.  Hefner voiced the existential perspec-
tive: “The primary question is not the preservation of the stem cells or
blastocyst [four- to six-day-old embryo], but how to transform it for God’s
purpose?  This moves away from self interest to God’s purposes.”  Scien-
tifically and philosophically, isolated stem cells are several divisions removed
from the capacity of the fertilized egg to develop into a human being.  On
the other hand, cloning could be used to generate another human being in
Stephen M. Modell 175
its (human) maker’s image, with all of the religious questions about sanc-
tity and individuality of human life attending such a procedure.  Overall, a
case can be made that the weight of argument lies in favor of consider-
ations such as societal benefit and human compassion, which have both
secular and religious footing.  Like genetic engineering, dialogue in the
general religious context tends to take a cautious yet favorable stance when
so many individuals may benefit.  A positive stance is qualified, however,
by the specifics of how such a resource would be generated and applied
and how the range of viewpoints would be practically melded into policy.
THE PLACE OF RELIGIOUS DIALOGUE IN THE PUBLIC DOMAIN
With each of the technologies considered, religion has served as a prime
contributor to discussion of whether and in what context a given applica-
tion should occur.  It serves as a “qualitative” check to the contention that
just because a technology is possible it should be launched into use (Con-
gregation for the Doctrine of the Faith 1987, 700).  The qualitative role
implies that religious principles and beliefs are capable of imposing more
than just an absolutist stamp on action.  They can suggest alternatives
based on the type of application envisioned and the circumstances involved.
The argument has been made that pressing the time of prenatal genetic
diagnosis earlier, from nine weeks back to the early multicellular stage fol-
lowing conception or even further back to preconceptual determination, is
one way to accommodate religious doctrines on decisions to be made for
future children who will suffer from serious genetic conditions.  Consider-
ation of circumstances, such as whether the life of the mother is seriously
imperiled by a pregnancy, can help to bring together opinion from differ-
ent faiths.
Decisions about societal or group use of genetic technology are rarely
simply objective.  Authors from diverse fields have remarked on the need
to balance scientifically based decisions with humanistic and spiritual per-
spectives.  In the health-policy domain, Julius Richmond and Milton Ko-
telchuck have presented a tripartite model of prevention policy (in Atwood,
Colditz, and Kawachi 1997, 1604).  For sound health policies to get made,
three factors—a scientific knowledge base, adequate political will, and a
suitably organized social strategy—must come together.  In a similar vein,
Roger Shinn has proposed a triangular model of science policymaking with
three corners: science (verifiable knowledge), politics (implementation of
public policy), and values (Shinn 1996, 71).  Values, he notes, embody
personal and group interests.  However, they also may transcend narrow
interests and extend people’s horizons.  This consideration is especially
important in the genetics field, where policy more often than not is set by
experts from the scientific-professional community and both commercial
and advocacy interests.  The third leg of policymaking often is missing.
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Conventional ethics can move toward supplying the final balance and,
indeed, has become a cottage industry in the biomedical field, but often it
is constrained by a principlist orientation or argumentation between prin-
ciplism (autonomy, privacy, and so on) and other countertheories, such as
deontology.  The public often bases value judgments on a broader set of
criteria.  Thus, a Kantian ethical approach stressing the noninstrumentality
of the individual—that people are ends in themselves and not means to an
end—still lacks the insight of Catholic personalism that individuals’ lives
are to be cherished because they integrally are persons in body, mind, and
spirit (Dailey and Leonard 2004, 2).  In a much-cited paper, James Gustaf-
son has parsed the different types of values-oriented discourse into four
varieties: ethical, prophetic, narrative, and policy discourse (1990, 127).
The tendency in the literature is to assign the religious voice to prophetic
discourse—for example, to the enunciation that activities like genetic en-
gineering of plants and animals are “playing God” (Evans 2001, 58).  How-
ever, it is closer to the truth that religious text issues principles that can also
be used in moral (as opposed to strictly secular ethical) arguments, covers
instances of human dilemma captured in medical literary narrative, and,
as used by a variety of denominations and umbrella religious organiza-
tions, can lead to policy recommendations at various formative levels.
Religious doctrine is an extremely versatile tool for shedding light on bio-
ethical, especially genetic, dilemmas, provided care is taken to configure its
language in a manner understood and appreciated by the other parties in
the conversation (Evans 2001, 64; Campbell 1999, 27).
Religious argument may be most complete when fashioned in exact align-
ment on the written page, but it is most persuasive, legitimate, and sincere
when engaging opposing viewpoints in real time.  Recent theological dip-
pings into the policy realm emphasize the importance of all participants in
a representative democracy, be they of the majority or the minority, being
able to express their religious views (Thiemann 1996, 21) and taking the
opportunity to voice their views alongside others in a communal setting.
Because of religious freedom, clerics of many persuasions were able to voice
through collective signatures their initial opposition to patenting life forms
for genetic engineering (Andrews 1995, A1) and later were able to publicly
express differing viewpoints on the tenacity of their opposition depending
on whether they had adopted vitalist or theistic viewpoints (all life sacred
versus God as sacred, life as derivative).  In our series the conversation
drifted from initial quandary during the second professional dialogue ses-
sion about how human beings could possibly patent life (“Isn’t ownership
of life the domain of God?”) to a more conclusive discussion in the third
symposium of what it means to act in the image of God under these cir-
cumstances for members of Islamic, Jewish, and Protestant faiths.  In each
of the above instances, one sees earnest dialogue taking place between rep-
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resentatives of various faiths and partaking members of the public (listen-
ing policymakers, the media, genetics conference participants).
The break point in the shaping of religious dialogue is the question of
what role it should perform in society.  As the professional dialogue series
gained momentum, its clerical moderator drew a distinction for the group
between descriptive theology and prescriptive ideology.  Dietrich Bonhoeffer
viewed the state (“the domain of politics”) as an ideological organ but
thought that the church should avoid ideology and remain descriptive in
its interpretation of doctrine (Bonhoeffer [1949] 2005, 50, 244).  The
group distinguished three levels of possible religious involvement: (1) dis-
cernment of ultimate principles, such as the sanctity of human life, the
image of God, and respect for human dignity; (2) elaboration of what is
right or wrong in human actions; and (3) involvement in the body politic.
Members thought it perfectly appropriate to discuss underlying principles,
but disagreement existed on whether religion should voice for society what
is morally acceptable.  Legislation was viewed as more a state than a church
activity.  Constitutional democracy places a premium on religious plural-
ism, which is a major reason for the reluctance of some members to move
into a moral advocacy role (Thiemann 1996, 21).  Nevertheless, a respect-
ful attitude toward religious pluralism need not lead to an absolute posi-
tion of normlessness or a paralysis in terms of judging morality for more
than just the self (Stackhouse 1987, 162).  Indeed, we found that the tech-
nologies under discussion have a tendency to evoke strong feelings of ne-
cessity or repugnance based on a person’s religious values.  Once the issues
(and emotions) are on the table, dialogue containing descriptive and pre-
scriptive elements can hardly be resisted.
Daniel Yankelovich, author of The Magic of Dialogue, defines dialogue
as a process of successful relationship building (Yankelovich 1999, 15).
Characteristically it is sustained—ideally over a year—and involves an ex-
change of values.  What shape should a religiously tolerant form of public
dialogue take?  A variety of faith-tradition sources have distinguished ele-
ments for effective dialogue between people or groups of different reli-
gious persuasions as well as between religious parties, industry, and the
scientific community (Hanson 2001, 103; Willer 2000, 59; Marty, Guinn,
and Greenfield 1998).  Common to these guidelines is the need to identify
the authentic religious dimensions, or contributions, within the dialogue;
need to avoid overreaction and absolutist stances; translations that make
communication clear and understandable to the other parties involved;
and explicit enunciation of values in expressions of concern or approval by
religious groups (Hanson 2001, 104–6; Marty, Guinn, and Greenfield 1998,
18–20).  Especially prominent in these writings is the tenet that the reli-
gious voice can contribute to policy dialogues on genetic technology.
Given that religion has a place in shaping genetic policy, two eventuali-
ties can materialize: consensus or disagreement.  Consensus certainly is
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welcome, but disagreement is not the end of the line.  Amy Gutmann and
Dennis Thompson contend that one purpose of dialogue (what they call
deliberation) is to promote mutually respectful decision making when in-
compatible moral values exist: “Through a deliberative process, partici-
pants can isolate those conflicts, such as abortion, that embody genuinely
incompatible values on both sides.  Conflicts that do not involve such
deep disagreement can then be [more] easily addressed” (Gutmann and
Thompson 1997, 40).  Ronald Thiemann writes in his Religion in Public
Life, “By acknowledging the moral force of an argument with which one
disagrees, a citizen remains open to the persuasive power of an alternative
point of view” (1996, 136).  The deliberative framework very much fits
the ongoing and iterative nature of the multiple discussions held between
professionals, religious figures, and public members in our dialogue series
and symposia over a three-year period.  There were some areas, such as the
beginning of human life and the measure of rights to be accorded an early
embryo, in which we ultimately decided to agree to disagree.  We moved
through technologies of greater and lesser degrees of values opposition and
found commonalities in the mutually agreed-upon stewardship of human-
ity alongside nature, a conservative approach to prenatal testing, and a
culturally respectful use of genetic interventions.
Gutmann and Thompson propose “an economy of moral disagreement”
when it comes to incompatible values, as has occurred in the abortion and
stem cell debates (Lustig 2002, 42).  “In justifying policies on moral grounds,
citizens should seek the rationale that minimizes rejection of the position
they oppose” (Gutmann and Thompson 1997, 40).  The principle of mini-
mal opposition is in keeping with the intent of this essay.  Middle zones
exist in the moral application of genetic and reproductive technologies,
where opposing parties may not have it entirely their way but the sting of
compromise will be reduced (Marty, Guinn, and Greenfield 1998, 25).
The motivation for seeking this ground is the reduction of human suffer-
ing, the enlargement of human compassion, and the expansion of benefit
in as wide a circle as possible.
AREAS OF CONVERGENCE IN GENETIC POLICY
The one generalization that can accurately be made regarding genetic and
reproductive technologies is that no final word exists on the policy deci-
sions that could be formulated.
It is likely that techniques that will remain unaffordable or unavailable
to the wider public for the near future, such as sperm-cell sorting, cyto-
plasmic and nuclear transfer, and cloning, will defy resolution on their
range of application and permissibility of use.
The techniques discussed herein have undergone considerable discus-
sion in the public eye and in professional circles.  The Genetic Frontiers
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series nicely captured the drift of discussion that has taken place and, be-
cause of the talent involved, added a seasoned perspective on the technolo-
gies and policies worth considering.
Prenatal genetic testing and fetal termination cannot be agreed on by
people of all faiths and levels of conservatism or liberality.  However, pre-
natal testing can be used to plan for a child, and other options, such as
preimplantation genetic diagnosis and preconceptual genetic testing, may
receive wider approval.  It is likely that gene therapy will never be widely
available and that its extension to the management of chronic disease and
aging will be superseded by more conventional regimens.  Debates regard-
ing plant and animal genetic engineering to feed the millions are often
energetic.  For some technologies, such as genetic engineering of foods,
religion serves as a regulatory device, suggesting what sorts of moral and
social considerations need to be addressed before a technology is widely
used.  Through active dialogue, people’s religious values can be weighed in
a balanced fashion and may lead to conclusion on techniques such as use
of human embryonic stem cells.
Different levels of communication can take place in the search for solu-
tions on how genetic technologies should be applied.  When communica-
tion between parties is heated and emotionally driven, it lapses into debate,
which can be divisive.  In contrast to debates, the reasoned discussion that
takes place at many professional conferences and in open public forums
can spread awareness of the issues and produce suggestions for further dis-
cussion.  If the discussion takes place over a period of time so that issues
and alternatives can be worked through, and if people’s underlying moral
values are given a chance for expression, the process of dialogue takes place.
CONCLUSION
The nine-part professional and three-part public conference series con-
ducted by the Genetic Frontiers program is an example of religious dia-
logue in its trial stages.  The process needs to be ongoing.  As often happens
with essays of this kind, readers may assume that the printed conclusions
represent final resolution of an issue.  This is not the case.  The conclusions
here represent the attempt to gather several persons’ thoughts into a coher-
ent whole to offer guidelines for future thought.  Working premises can
later be strengthened or washed away.  Not that religious dialogue on sci-
entific topics is meant to lead to consensus, but it may start a process that
can lead to areas of satisfactory, if temporary, agreement while instilling
mutual respect for others’ opinions where agreement cannot be achieved.
In the beginning stages, participants in dialogue find a common language
that allows the communication to continue.
Religious dialogue can be used to get around the polarities of interest
groups and pressure politics.  The applications of religious thought in the
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present millennium have evolved considerably beyond the casting of simple
prohibitions.  They can serve as a regulatory device in the setting of genetic
and reproductive policy.  Religious dialogue incorporates the principles of
ethics and moves onward from there.  At a certain point, after a critical
mass of religious thought is brought into the open and collectively agreed
on, humane approaches toward the use of genetic and reproductive tech-
nologies surface.
NOTE
A version of this essay was presented at the fifth Metanexus annual conference, “Science and
Religion in Context,” University of Pennsylvania, 5–9 June 2004.  The project discussed, “Ge-
netic Frontiers: Challenges for Humanity and Our Religious Traditions,” received major sup-
port from a Metanexus Local Societies Initiative grant.
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